Rani Therapeutics signs $1 billion potential deal with Chugai for oral biologics
PositiveFinancial Markets

Rani Therapeutics has entered into a significant potential deal worth $1 billion with Chugai Pharmaceutical to develop oral biologics. This partnership is a major step forward in the field of drug delivery, as it aims to make biologic medications more accessible and easier to administer. The collaboration highlights the growing interest in innovative solutions for patient care and could lead to groundbreaking advancements in how chronic diseases are treated.
— Curated by the World Pulse Now AI Editorial System